

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.47088996 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.47088996 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.16713110 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.16713110 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.74138162 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.55148025 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.17489097 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.17489097 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.17489097 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.09100325 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.99953934 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.79969100 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.77966257 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.72390803 |
| 15 | urea metabolic process (GO:0019627) | 5.61095383 |
| 16 | urea cycle (GO:0000050) | 5.61095383 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.59631131 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.52873237 |
| 19 | cysteine metabolic process (GO:0006534) | 5.47499415 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.35606277 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.35542688 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.34240937 |
| 23 | protein carboxylation (GO:0018214) | 5.34240937 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.28584751 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.22207837 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.16640544 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.15335433 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.15268423 |
| 29 | bile acid metabolic process (GO:0008206) | 5.12238755 |
| 30 | response to peptidoglycan (GO:0032494) | 5.00864904 |
| 31 | negative regulation of cell killing (GO:0031342) | 5.00464368 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.00464368 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.95261414 |
| 34 | regulation of complement activation (GO:0030449) | 4.92257109 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.91246629 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.90809022 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.88520857 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 4.87230411 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 4.84109394 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.79548616 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.76994803 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76994803 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.76994803 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.72504365 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.72504365 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 4.71386311 |
| 47 | phospholipid efflux (GO:0033700) | 4.68273642 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.68026160 |
| 49 | positive regulation by symbiont of host defense response (GO:0052509) | 4.67789282 |
| 50 | modulation by symbiont of host defense response (GO:0052031) | 4.67789282 |
| 51 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.67789282 |
| 52 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.67789282 |
| 53 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.67789282 |
| 54 | modulation by symbiont of host immune response (GO:0052553) | 4.67789282 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.67688303 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.67688303 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.65765014 |
| 58 | homocysteine metabolic process (GO:0050667) | 4.64440331 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 4.61706212 |
| 60 | lysine catabolic process (GO:0006554) | 4.58208529 |
| 61 | lysine metabolic process (GO:0006553) | 4.58208529 |
| 62 | glycine metabolic process (GO:0006544) | 4.56138396 |
| 63 | detection of other organism (GO:0098543) | 4.54404887 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.53607568 |
| 65 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.48419744 |
| 66 | cellular ketone body metabolic process (GO:0046950) | 4.48413130 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.46871305 |
| 68 | detection of bacterium (GO:0016045) | 4.46350419 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 4.45756901 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.45157783 |
| 71 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44902965 |
| 72 | coenzyme catabolic process (GO:0009109) | 4.42176897 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 4.36437027 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 4.35246010 |
| 75 | cholesterol efflux (GO:0033344) | 4.28052499 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.27370144 |
| 77 | glutamate metabolic process (GO:0006536) | 4.26847611 |
| 78 | amine catabolic process (GO:0009310) | 4.24322221 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 4.24322221 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 4.24024403 |
| 81 | ethanol oxidation (GO:0006069) | 4.23444428 |
| 82 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.21077082 |
| 83 | cellular glucuronidation (GO:0052695) | 4.20497720 |
| 84 | serine family amino acid biosynthetic process (GO:0009070) | 4.17440563 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 4.08676318 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 4.08649807 |
| 87 | type I interferon signaling pathway (GO:0060337) | 4.07377605 |
| 88 | cellular response to type I interferon (GO:0071357) | 4.07377605 |
| 89 | response to type I interferon (GO:0034340) | 4.05542681 |
| 90 | cellular modified amino acid catabolic process (GO:0042219) | 4.05205176 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.03670949 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.03670949 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01010245 |
| 94 | arginine metabolic process (GO:0006525) | 3.96333448 |
| 95 | aldehyde catabolic process (GO:0046185) | 3.95427366 |
| 96 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93531953 |
| 97 | drug catabolic process (GO:0042737) | 3.92869109 |
| 98 | detection of external biotic stimulus (GO:0098581) | 3.91120279 |
| 99 | fibrinolysis (GO:0042730) | 3.89744777 |
| 100 | ketone body metabolic process (GO:1902224) | 3.87988189 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 3.86812407 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.82667336 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.82349936 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.78118311 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.77172076 |
| 106 | cofactor catabolic process (GO:0051187) | 3.77168931 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.74660124 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.73447790 |
| 109 | organic acid catabolic process (GO:0016054) | 3.73447790 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 3.72533695 |
| 111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.71673641 |
| 112 | sterol homeostasis (GO:0055092) | 3.71314695 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 3.69670400 |
| 114 | uronic acid metabolic process (GO:0006063) | 3.69450397 |
| 115 | glucuronate metabolic process (GO:0019585) | 3.69450397 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69402501 |
| 117 | complement activation (GO:0006956) | 3.69315079 |
| 118 | detection of molecule of bacterial origin (GO:0032490) | 3.69313163 |
| 119 | protein activation cascade (GO:0072376) | 3.68278334 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.66809301 |
| 121 | cytolysis (GO:0019835) | 3.65481731 |
| 122 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.64335225 |
| 123 | plasma lipoprotein particle organization (GO:0071827) | 3.64139058 |
| 124 | phospholipid homeostasis (GO:0055091) | 3.63991114 |
| 125 | negative regulation of lipase activity (GO:0060192) | 3.62681411 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 3.62275720 |
| 127 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.60714058 |
| 128 | leukocyte aggregation (GO:0070486) | 3.60137964 |
| 129 | short-chain fatty acid metabolic process (GO:0046459) | 3.59559736 |
| 130 | opsonization (GO:0008228) | 3.57423461 |
| 131 | NIK/NF-kappaB signaling (GO:0038061) | 3.56237762 |
| 132 | germinal center formation (GO:0002467) | 3.52439200 |
| 133 | positive regulation of antigen processing and presentation (GO:0002579) | 3.48750499 |
| 134 | regulation of gamma-delta T cell activation (GO:0046643) | 3.47754380 |
| 135 | detection of biotic stimulus (GO:0009595) | 3.43683821 |
| 136 | regulation of antigen processing and presentation (GO:0002577) | 3.42760100 |
| 137 | regulation of mast cell degranulation (GO:0043304) | 3.41785535 |
| 138 | defense response to protozoan (GO:0042832) | 3.38068627 |
| 139 | macrophage activation (GO:0042116) | 3.33656374 |
| 140 | response to muramyl dipeptide (GO:0032495) | 3.33556509 |
| 141 | respiratory burst (GO:0045730) | 3.33316835 |
| 142 | granulocyte activation (GO:0036230) | 3.32418581 |
| 143 | B cell mediated immunity (GO:0019724) | 3.31054172 |
| 144 | myeloid cell activation involved in immune response (GO:0002275) | 3.29786126 |
| 145 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.29201308 |
| 146 | T-helper 1 type immune response (GO:0042088) | 3.29135225 |
| 147 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28434622 |
| 148 | myeloid dendritic cell differentiation (GO:0043011) | 3.26968354 |
| 149 | cellular extravasation (GO:0045123) | 3.26783862 |
| 150 | regulation of T cell tolerance induction (GO:0002664) | 3.26668590 |
| 151 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26319568 |
| 152 | neutrophil activation (GO:0042119) | 3.22842904 |
| 153 | response to protozoan (GO:0001562) | 3.16852027 |
| 154 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.15785336 |
| 155 | response to host immune response (GO:0052572) | 3.15082787 |
| 156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.15082787 |
| 157 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.15045612 |
| 158 | regulation of tolerance induction (GO:0002643) | 3.12958825 |
| 159 | regulation of interferon-alpha production (GO:0032647) | 3.12223911 |
| 160 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.12113933 |
| 161 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.12045801 |
| 162 | microglial cell activation (GO:0001774) | 3.09239794 |
| 163 | positive regulation of type 2 immune response (GO:0002830) | 3.06952296 |
| 164 | myeloid dendritic cell activation (GO:0001773) | 3.05728163 |
| 165 | regulation of leukocyte degranulation (GO:0043300) | 3.05292005 |
| 166 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.03982622 |
| 167 | positive regulation of interferon-alpha production (GO:0032727) | 3.03308067 |
| 168 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00649329 |
| 169 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00577810 |
| 170 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99822565 |
| 171 | positive regulation of mast cell activation (GO:0033005) | 2.98189767 |
| 172 | negative regulation of innate immune response (GO:0045824) | 2.97757910 |
| 173 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97565918 |
| 174 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96612169 |
| 175 | cellular response to interferon-gamma (GO:0071346) | 2.94740822 |
| 176 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.91663540 |
| 177 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.90160873 |
| 178 | response to host (GO:0075136) | 2.87788573 |
| 179 | response to host defenses (GO:0052200) | 2.87788573 |
| 180 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.87788573 |
| 181 | regulation of mast cell activation (GO:0033003) | 2.85097672 |
| 182 | response to interferon-gamma (GO:0034341) | 2.84804116 |
| 183 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.84165377 |
| 184 | positive regulation of mast cell degranulation (GO:0043306) | 2.84165377 |
| 185 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.82602728 |
| 186 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.77718826 |
| 187 | regulation of type 2 immune response (GO:0002828) | 2.77417718 |
| 188 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.75537548 |
| 189 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71535011 |
| 190 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.71256954 |
| 191 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.71031306 |
| 192 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.68168532 |
| 193 | myeloid leukocyte activation (GO:0002274) | 2.67605202 |
| 194 | lymphocyte chemotaxis (GO:0048247) | 2.67449663 |
| 195 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.66264030 |
| 196 | amino sugar catabolic process (GO:0046348) | 2.66075283 |
| 197 | T cell migration (GO:0072678) | 2.65639361 |
| 198 | regulation of interleukin-12 production (GO:0032655) | 2.64968873 |
| 199 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.63716627 |
| 200 | regulation of podosome assembly (GO:0071801) | 2.60828600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39386281 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.29162406 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.03349422 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44861557 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21678947 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18060509 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85125053 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.21817258 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.12349493 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.02248594 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89040887 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06828555 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03777397 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89482485 |
| 15 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.89377841 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70074209 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55950375 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.55900382 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.46941151 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.21651433 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.18417045 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10505324 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10367957 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.08005150 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06812388 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04331965 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02861683 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01326431 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01044665 |
| 30 | * MAF_26560356_Chip-Seq_TH1_Human | 2.00324892 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9815239 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92845246 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.89900037 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.80257275 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79485844 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76375535 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74006720 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72092989 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71725451 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71387388 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70824842 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69414875 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.69041049 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65385857 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64285039 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63042468 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62094051 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60967015 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59897781 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.59436587 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49514697 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.47645077 |
| 53 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43699355 |
| 54 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42382016 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40388150 |
| 56 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40007582 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38567990 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38510992 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38335010 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38008884 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37444938 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33397429 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32679170 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.31491251 |
| 65 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.30453891 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30076950 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29586477 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28415463 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27931359 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.27777248 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25982386 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24587784 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22105153 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21969950 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20410459 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19051281 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16304459 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16303931 |
| 79 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15327851 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.15067680 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13971917 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13650946 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11103941 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10618593 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09975854 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09285861 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09097725 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08295752 |
| 89 | P68_20966046_ChIP-Seq_HELA_Human | 1.06994160 |
| 90 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06355480 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03637892 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03310529 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00977476 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00672254 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97985110 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96992945 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96274770 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96017192 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95957223 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94711369 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94670312 |
| 102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93725016 |
| 103 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93284567 |
| 104 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92825276 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91433960 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91367782 |
| 107 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88617521 |
| 108 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88338482 |
| 109 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.86131434 |
| 110 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83365045 |
| 111 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83241405 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82811651 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82467457 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80221454 |
| 115 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78148025 |
| 116 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.75755437 |
| 117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75513832 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73733144 |
| 119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73241804 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.71093451 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70313848 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69806274 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68505073 |
| 124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67835834 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62704245 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60103144 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.58608040 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58350217 |
| 129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57878404 |
| 130 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.55741835 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.55614827 |
| 132 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54797114 |
| 133 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.54339804 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53829085 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.53562447 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53418379 |
| 137 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.51797881 |
| 138 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51613418 |
| 139 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50316722 |
| 140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49754018 |
| 141 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.49460316 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.49315995 |
| 143 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.47881518 |
| 144 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46973580 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46782967 |
| 146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46388293 |
| 147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.46366121 |
| 148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.45811822 |
| 149 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.45434550 |
| 150 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.45406780 |
| 151 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.45314819 |
| 152 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44888291 |
| 153 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44855724 |
| 154 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44731981 |
| 155 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44703404 |
| 156 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44398655 |
| 157 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.44084126 |
| 158 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.43553834 |
| 159 | CBP_21632823_ChIP-Seq_H3396_Human | 0.42139189 |
| 160 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.41512391 |
| 161 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.41512391 |
| 162 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41257338 |
| 163 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41174864 |
| 164 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.41014417 |
| 165 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.40469081 |
| 166 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39895567 |
| 167 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.39721486 |
| 168 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39622701 |
| 169 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39422601 |
| 170 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.38974992 |
| 171 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38535459 |
| 172 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.38283936 |
| 173 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38189447 |
| 174 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.38023014 |
| 175 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.37934419 |
| 176 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.37794878 |
| 177 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.36818702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.44272057 |
| 2 | MP0005360_urolithiasis | 7.73642461 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.39019757 |
| 4 | MP0005365_abnormal_bile_salt | 6.17103543 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10362411 |
| 6 | MP0003303_peritoneal_inflammation | 4.19045901 |
| 7 | MP0003252_abnormal_bile_duct | 3.99131428 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.65788575 |
| 9 | MP0009840_abnormal_foam_cell | 3.50198445 |
| 10 | * MP0003806_abnormal_nucleotide_metabolis | 3.48517126 |
| 11 | MP0001835_abnormal_antigen_presentation | 3.48505680 |
| 12 | MP0009785_altered_susceptibility_to | 3.21872849 |
| 13 | MP0005083_abnormal_biliary_tract | 3.02305942 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.98976600 |
| 15 | MP0002419_abnormal_innate_immunity | 2.97230658 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.97078526 |
| 17 | MP0001790_abnormal_immune_system | 2.95558029 |
| 18 | MP0005387_immune_system_phenotype | 2.95558029 |
| 19 | MP0005025_abnormal_response_to | 2.87913011 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.82612297 |
| 21 | MP0005671_abnormal_response_to | 2.78445794 |
| 22 | MP0003195_calcinosis | 2.75136260 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.74993550 |
| 24 | MP0005332_abnormal_amino_acid | 2.72522038 |
| 25 | * MP0006082_CNS_inflammation | 2.71037272 |
| 26 | MP0000685_abnormal_immune_system | 2.58896222 |
| 27 | MP0004510_myositis | 2.48975181 |
| 28 | MP0001800_abnormal_humoral_immune | 2.48804124 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.40176949 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 2.38436226 |
| 31 | MP0002452_abnormal_antigen_presenting | 2.36449880 |
| 32 | MP0002723_abnormal_immune_serum | 2.35729661 |
| 33 | MP0003172_abnormal_lysosome_physiology | 2.23680577 |
| 34 | MP0001533_abnormal_skeleton_physiology | 2.22074888 |
| 35 | MP0000609_abnormal_liver_physiology | 2.21943407 |
| 36 | MP0002420_abnormal_adaptive_immunity | 2.12028951 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 2.11786178 |
| 38 | MP0001819_abnormal_immune_cell | 2.11655729 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 2.06707741 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.98159066 |
| 41 | MP0009278_abnormal_bone_marrow | 1.96475570 |
| 42 | MP0004947_skin_inflammation | 1.90793208 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.84139079 |
| 44 | MP0002405_respiratory_system_inflammati | 1.81620256 |
| 45 | * MP0005319_abnormal_enzyme/_coenzyme | 1.81032251 |
| 46 | MP0003868_abnormal_feces_composition | 1.80836854 |
| 47 | MP0000343_altered_response_to | 1.71405428 |
| 48 | MP0001764_abnormal_homeostasis | 1.70869781 |
| 49 | MP0009697_abnormal_copulation | 1.67166914 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.57916166 |
| 51 | MP0005310_abnormal_salivary_gland | 1.57167874 |
| 52 | MP0008260_abnormal_autophagy | 1.55291609 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.52891859 |
| 54 | MP0000716_abnormal_immune_system | 1.52557237 |
| 55 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.51274679 |
| 56 | MP0005451_abnormal_body_composition | 1.49786165 |
| 57 | MP0000858_altered_metastatic_potential | 1.49746634 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.41884341 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.41025885 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.41025885 |
| 61 | MP0002398_abnormal_bone_marrow | 1.34201896 |
| 62 | MP0003448_altered_tumor_morphology | 1.32824870 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.31193603 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.30977124 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.28083992 |
| 66 | MP0003011_delayed_dark_adaptation | 1.27365027 |
| 67 | MP0003828_pulmonary_edema | 1.26305502 |
| 68 | MP0003186_abnormal_redox_activity | 1.24280513 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.23914680 |
| 70 | MP0000598_abnormal_liver_morphology | 1.20488284 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.17794880 |
| 72 | MP0002429_abnormal_blood_cell | 1.17697379 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.17329743 |
| 74 | MP0005647_abnormal_sex_gland | 1.15643860 |
| 75 | MP0001873_stomach_inflammation | 1.14097459 |
| 76 | MP0008004_abnormal_stomach_pH | 1.13862446 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.13217560 |
| 78 | MP0000604_amyloidosis | 1.12903552 |
| 79 | MP0002722_abnormal_immune_system | 1.07997032 |
| 80 | MP0009764_decreased_sensitivity_to | 1.07293895 |
| 81 | MP0005164_abnormal_response_to | 1.03049098 |
| 82 | MP0003866_abnormal_defecation | 1.02861291 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 1.02818450 |
| 84 | MP0009763_increased_sensitivity_to | 1.02352130 |
| 85 | MP0002933_joint_inflammation | 0.99724328 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.99235220 |
| 87 | MP0001851_eye_inflammation | 0.98407041 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.98142127 |
| 89 | MP0002254_reproductive_system_inflammat | 0.97983788 |
| 90 | MP0005636_abnormal_mineral_homeostasis | 0.97601797 |
| 91 | MP0005390_skeleton_phenotype | 0.97397531 |
| 92 | MP0001663_abnormal_digestive_system | 0.95960322 |
| 93 | MP0008469_abnormal_protein_level | 0.94094816 |
| 94 | MP0009642_abnormal_blood_homeostasis | 0.90326509 |
| 95 | MP0006054_spinal_hemorrhage | 0.86121872 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.84660699 |
| 97 | MP0003091_abnormal_cell_migration | 0.80251983 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.78718635 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.77973105 |
| 100 | MP0003795_abnormal_bone_structure | 0.77197829 |
| 101 | * MP0006036_abnormal_mitochondrial_physio | 0.77053892 |
| 102 | * MP0005376_homeostasis/metabolism_phenot | 0.76792867 |
| 103 | MP0005408_hypopigmentation | 0.76474533 |
| 104 | MP0002971_abnormal_brown_adipose | 0.74079521 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.71527050 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.71125214 |
| 107 | MP0005334_abnormal_fat_pad | 0.70403712 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.69829332 |
| 109 | MP0005670_abnormal_white_adipose | 0.69584324 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.69131145 |
| 111 | MP0004858_abnormal_nervous_system | 0.68158162 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.67095951 |
| 113 | MP0003329_amyloid_beta_deposits | 0.65924877 |
| 114 | MP0005023_abnormal_wound_healing | 0.65558380 |
| 115 | MP0000920_abnormal_myelination | 0.64756457 |
| 116 | MP0000490_abnormal_crypts_of | 0.63801488 |
| 117 | MP0001661_extended_life_span | 0.63777424 |
| 118 | MP0009053_abnormal_anal_canal | 0.62815260 |
| 119 | MP0005535_abnormal_body_temperature | 0.62683748 |
| 120 | MP0003279_aneurysm | 0.62563804 |
| 121 | MP0001849_ear_inflammation | 0.61501702 |
| 122 | MP0001542_abnormal_bone_strength | 0.61184914 |
| 123 | MP0005464_abnormal_platelet_physiology | 0.60374164 |
| 124 | MP0005448_abnormal_energy_balance | 0.59757788 |
| 125 | MP0004130_abnormal_muscle_cell | 0.59212597 |
| 126 | * MP0005266_abnormal_metabolism | 0.59200225 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.58885585 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.58143020 |
| 129 | MP0005165_increased_susceptibility_to | 0.55597171 |
| 130 | MP0001756_abnormal_urination | 0.55345145 |
| 131 | MP0003045_fibrosis | 0.55075476 |
| 132 | MP0003690_abnormal_glial_cell | 0.53050230 |
| 133 | MP0003436_decreased_susceptibility_to | 0.52014019 |
| 134 | MP0002822_catalepsy | 0.51714057 |
| 135 | MP0003718_maternal_effect | 0.50049711 |
| 136 | MP0003638_abnormal_response/metabolism_ | 0.47982851 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.47568627 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.46442323 |
| 139 | MP0005395_other_phenotype | 0.46191277 |
| 140 | MP0002928_abnormal_bile_duct | 0.46050244 |
| 141 | MP0008873_increased_physiological_sensi | 0.45617852 |
| 142 | MP0003724_increased_susceptibility_to | 0.44958388 |
| 143 | MP0008874_decreased_physiological_sensi | 0.44218812 |
| 144 | MP0005166_decreased_susceptibility_to | 0.43381697 |
| 145 | * MP0006035_abnormal_mitochondrial_morpho | 0.42305914 |
| 146 | MP0003953_abnormal_hormone_level | 0.41668654 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.40247858 |
| 148 | MP0003075_altered_response_to | 0.39481174 |
| 149 | MP0004381_abnormal_hair_follicle | 0.38527676 |
| 150 | MP0002132_abnormal_respiratory_system | 0.37534265 |
| 151 | MP0008872_abnormal_physiological_respon | 0.37205167 |
| 152 | MP0009115_abnormal_fat_cell | 0.34782391 |
| 153 | MP0001853_heart_inflammation | 0.34486460 |
| 154 | MP0000249_abnormal_blood_vessel | 0.33596247 |
| 155 | MP0002970_abnormal_white_adipose | 0.32772566 |
| 156 | MP0001845_abnormal_inflammatory_respons | 0.32748373 |
| 157 | MP0005666_abnormal_adipose_tissue | 0.32481839 |
| 158 | MP0002796_impaired_skin_barrier | 0.32355680 |
| 159 | MP0002837_dystrophic_cardiac_calcinosis | 0.32071251 |
| 160 | MP0001243_abnormal_dermal_layer | 0.31355317 |
| 161 | MP0009672_abnormal_birth_weight | 0.31326952 |
| 162 | MP0000230_abnormal_systemic_arterial | 0.31067279 |
| 163 | MP0005248_abnormal_Harderian_gland | 0.30817529 |
| 164 | MP0004264_abnormal_extraembryonic_tissu | 0.27098899 |
| 165 | MP0001881_abnormal_mammary_gland | 0.26993619 |
| 166 | MP0000579_abnormal_nail_morphology | 0.24768477 |
| 167 | MP0004883_abnormal_blood_vessel | 0.24141023 |
| 168 | MP0002168_other_aberrant_phenotype | 0.23851437 |
| 169 | MP0002135_abnormal_kidney_morphology | 0.23778513 |
| 170 | MP0004147_increased_porphyrin_level | 0.23315578 |
| 171 | MP0000427_abnormal_hair_cycle | 0.22851088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.33988233 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.28736983 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.24165455 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.66126339 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60724928 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.49037470 |
| 7 | Xanthomatosis (HP:0000991) | 6.27291077 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.98550352 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.51245686 |
| 10 | Abnormality of macrophages (HP:0004311) | 5.50918742 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 5.37814873 |
| 12 | Recurrent abscess formation (HP:0002722) | 5.27267448 |
| 13 | Complement deficiency (HP:0004431) | 5.21363996 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.92953094 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.92953094 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 4.92953094 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.83799970 |
| 18 | Myositis (HP:0100614) | 4.79302759 |
| 19 | Joint hemorrhage (HP:0005261) | 4.67801973 |
| 20 | Orchitis (HP:0100796) | 4.60269550 |
| 21 | Hyperammonemia (HP:0001987) | 4.58372213 |
| 22 | Hyperglycinemia (HP:0002154) | 4.52637516 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.41362654 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39559405 |
| 25 | Epidermoid cyst (HP:0200040) | 4.39245388 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 4.29826018 |
| 27 | Optic neuritis (HP:0100653) | 4.29826018 |
| 28 | Fat malabsorption (HP:0002630) | 4.25140310 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22264872 |
| 30 | Ketosis (HP:0001946) | 4.19949048 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13052469 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 4.06592774 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 4.06031392 |
| 34 | Hyperglycinuria (HP:0003108) | 4.01011584 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.99835711 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.99668115 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99668115 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.99502987 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 3.87656764 |
| 40 | Hypoglycemic coma (HP:0001325) | 3.86883969 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.84959732 |
| 42 | Stomatitis (HP:0010280) | 3.81575096 |
| 43 | Abnormality of complement system (HP:0005339) | 3.80987822 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80072293 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76502473 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.69055817 |
| 47 | Loss of speech (HP:0002371) | 3.62604598 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.59662617 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 3.55984812 |
| 50 | Obstructive lung disease (HP:0006536) | 3.55984812 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.50740952 |
| 52 | Dysostosis multiplex (HP:0000943) | 3.46163699 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41849108 |
| 54 | Recurrent fungal infections (HP:0002841) | 3.41094508 |
| 55 | Hyperbilirubinemia (HP:0002904) | 3.40735879 |
| 56 | Recurrent skin infections (HP:0001581) | 3.40661481 |
| 57 | Increased IgE level (HP:0003212) | 3.20339950 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 3.19947792 |
| 59 | Gingivitis (HP:0000230) | 3.18911284 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.17742867 |
| 61 | Steatorrhea (HP:0002570) | 3.15313929 |
| 62 | Meningitis (HP:0001287) | 3.15255380 |
| 63 | Delayed CNS myelination (HP:0002188) | 3.13911325 |
| 64 | Spontaneous abortion (HP:0005268) | 3.13108851 |
| 65 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07356361 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 3.06457840 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 3.05489949 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 3.03127116 |
| 69 | Vasculitis (HP:0002633) | 3.02884315 |
| 70 | Disinhibition (HP:0000734) | 3.01927166 |
| 71 | Ketoacidosis (HP:0001993) | 2.99259769 |
| 72 | Myocardial infarction (HP:0001658) | 2.96942428 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.89682940 |
| 74 | Hemoptysis (HP:0002105) | 2.88597833 |
| 75 | Hepatocellular carcinoma (HP:0001402) | 2.87862653 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.86507451 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83841707 |
| 78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83841707 |
| 79 | Hypochromic microcytic anemia (HP:0004840) | 2.83251606 |
| 80 | Metabolic acidosis (HP:0001942) | 2.83149806 |
| 81 | Purpura (HP:0000979) | 2.80559493 |
| 82 | Increased serum ferritin (HP:0003281) | 2.79975808 |
| 83 | Urticaria (HP:0001025) | 2.79527383 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.78244990 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.75476014 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.75476014 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.75476014 |
| 88 | Acanthocytosis (HP:0001927) | 2.74709298 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 2.72783305 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.68421459 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 2.67944923 |
| 92 | Encephalitis (HP:0002383) | 2.67692048 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.67238778 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 2.67238778 |
| 95 | Skin nodule (HP:0200036) | 2.67082324 |
| 96 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62760367 |
| 97 | Recurrent viral infections (HP:0004429) | 2.61916052 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 2.60775658 |
| 99 | Vascular calcification (HP:0004934) | 2.60444729 |
| 100 | Lethargy (HP:0001254) | 2.59494119 |
| 101 | Cellulitis (HP:0100658) | 2.58529600 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58228115 |
| 103 | Mucopolysacchariduria (HP:0008155) | 2.58228115 |
| 104 | Petechiae (HP:0000967) | 2.57853010 |
| 105 | Colitis (HP:0002583) | 2.57554905 |
| 106 | Abnormal gallbladder physiology (HP:0012438) | 2.50235744 |
| 107 | Cholecystitis (HP:0001082) | 2.50235744 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 2.48103885 |
| 109 | Hypoglycemic seizures (HP:0002173) | 2.47164208 |
| 110 | Cholelithiasis (HP:0001081) | 2.45168404 |
| 111 | Increased IgM level (HP:0003496) | 2.44525269 |
| 112 | Gout (HP:0001997) | 2.42750826 |
| 113 | Spastic diplegia (HP:0001264) | 2.41960725 |
| 114 | Axonal loss (HP:0003447) | 2.40990782 |
| 115 | Inflammation of the large intestine (HP:0002037) | 2.40513712 |
| 116 | Mutism (HP:0002300) | 2.40074725 |
| 117 | Nasal polyposis (HP:0100582) | 2.38501291 |
| 118 | Pustule (HP:0200039) | 2.35281048 |
| 119 | Mitral stenosis (HP:0001718) | 2.35179302 |
| 120 | Glomerulonephritis (HP:0000099) | 2.33500910 |
| 121 | Neonatal onset (HP:0003623) | 2.32910095 |
| 122 | Cerebral edema (HP:0002181) | 2.32395127 |
| 123 | Gastrointestinal inflammation (HP:0004386) | 2.31493098 |
| 124 | Premature loss of primary teeth (HP:0006323) | 2.30802375 |
| 125 | Cardiovascular calcification (HP:0011915) | 2.30247993 |
| 126 | Irritability (HP:0000737) | 2.28454516 |
| 127 | Late onset (HP:0003584) | 2.27255076 |
| 128 | Brushfield spots (HP:0001088) | 2.27074500 |
| 129 | Interstitial pulmonary disease (HP:0006530) | 2.26563144 |
| 130 | Hypergammaglobulinemia (HP:0010702) | 2.26301307 |
| 131 | Hepatosplenomegaly (HP:0001433) | 2.25542539 |
| 132 | Chest pain (HP:0100749) | 2.25255719 |
| 133 | Gangrene (HP:0100758) | 2.24278174 |
| 134 | Amyloidosis (HP:0011034) | 2.24179658 |
| 135 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22075166 |
| 136 | Sensorimotor neuropathy (HP:0007141) | 2.21849188 |
| 137 | Gingival bleeding (HP:0000225) | 2.20879773 |
| 138 | Anorexia (HP:0002039) | 2.19952676 |
| 139 | Poikilocytosis (HP:0004447) | 2.19791308 |
| 140 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19024354 |
| 141 | Pulmonary embolism (HP:0002204) | 2.18346898 |
| 142 | Episodic fever (HP:0001954) | 2.18127725 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 2.17964179 |
| 144 | Arterial thrombosis (HP:0004420) | 2.16768865 |
| 145 | Pancreatitis (HP:0001733) | 2.15789625 |
| 146 | Hematochezia (HP:0002573) | 2.15777617 |
| 147 | Opisthotonus (HP:0002179) | 2.15102061 |
| 148 | Hemorrhage of the eye (HP:0011885) | 2.15031005 |
| 149 | Neurofibrillary tangles (HP:0002185) | 2.14954978 |
| 150 | Prolonged bleeding time (HP:0003010) | 2.14335572 |
| 151 | Esophageal varix (HP:0002040) | 2.12744518 |
| 152 | Epistaxis (HP:0000421) | 2.12597368 |
| 153 | Thrombophlebitis (HP:0004418) | 2.12571538 |
| 154 | Leukocytosis (HP:0001974) | 2.12232632 |
| 155 | Menorrhagia (HP:0000132) | 2.10306320 |
| 156 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09878868 |
| 157 | Osteomyelitis (HP:0002754) | 2.08603806 |
| 158 | Gastrointestinal stroma tumor (HP:0100723) | 2.06678375 |
| 159 | T lymphocytopenia (HP:0005403) | 2.06013911 |
| 160 | Generalized aminoaciduria (HP:0002909) | 2.05455231 |
| 161 | Enlarged kidneys (HP:0000105) | 2.03169414 |
| 162 | Abnormality of the gallbladder (HP:0005264) | 2.03143422 |
| 163 | Abnormality of the pleura (HP:0002103) | 2.01320178 |
| 164 | Progressive neurologic deterioration (HP:0002344) | 2.00811029 |
| 165 | Chronic otitis media (HP:0000389) | 2.00191959 |
| 166 | Nuclear cataract (HP:0100018) | 2.00063301 |
| 167 | * Vomiting (HP:0002013) | 1.99796537 |
| 168 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99573564 |
| 169 | Abnormality of proline metabolism (HP:0010907) | 1.99219282 |
| 170 | Hydroxyprolinuria (HP:0003080) | 1.99219282 |
| 171 | Restrictive lung disease (HP:0002091) | 1.98727455 |
| 172 | Abnormality of iron homeostasis (HP:0011031) | 1.97826856 |
| 173 | Abnormality of T cell number (HP:0011839) | 1.97560127 |
| 174 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96930423 |
| 175 | Polyneuropathy (HP:0001271) | 1.96180073 |
| 176 | Acne (HP:0001061) | 1.93243110 |
| 177 | Elevated hepatic transaminases (HP:0002910) | 1.89079235 |
| 178 | Upper motor neuron abnormality (HP:0002127) | 1.88874866 |
| 179 | Thin bony cortex (HP:0002753) | 1.88461912 |
| 180 | Reticulocytosis (HP:0001923) | 1.87523980 |
| 181 | Recurrent pneumonia (HP:0006532) | 1.86238398 |
| 182 | Rickets (HP:0002748) | 1.84225005 |
| 183 | Abnormal cartilage morphology (HP:0002763) | 1.84185755 |
| 184 | Renal cortical cysts (HP:0000803) | 1.80689200 |
| 185 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76487475 |
| 186 | Abnormality of vitamin metabolism (HP:0100508) | 1.75492324 |
| 187 | Status epilepticus (HP:0002133) | 1.74784881 |
| 188 | Glycosuria (HP:0003076) | 1.70367557 |
| 189 | Abnormality of urine glucose concentration (HP:0011016) | 1.70367557 |
| 190 | Hypophosphatemic rickets (HP:0004912) | 1.69147357 |
| 191 | Nephritis (HP:0000123) | 1.67738994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.14007156 |
| 2 | ERN1 | 4.93568178 |
| 3 | FGFR4 | 4.61663516 |
| 4 | SIK1 | 4.60642009 |
| 5 | RIPK4 | 3.85633509 |
| 6 | BLK | 3.41501123 |
| 7 | TAOK3 | 3.26087158 |
| 8 | IRAK4 | 2.60523275 |
| 9 | ERBB4 | 2.57783625 |
| 10 | INSRR | 2.55950120 |
| 11 | FLT3 | 2.17822520 |
| 12 | PRPF4B | 2.16173958 |
| 13 | PKN2 | 2.11138757 |
| 14 | TAOK1 | 2.05479658 |
| 15 | MAP2K4 | 2.04583509 |
| 16 | MST1R | 2.01764659 |
| 17 | PIK3CG | 2.00249683 |
| 18 | FGR | 1.98687139 |
| 19 | TRIB3 | 1.92956893 |
| 20 | TYK2 | 1.92399198 |
| 21 | MAPK11 | 1.83754696 |
| 22 | TNK2 | 1.82623833 |
| 23 | NME2 | 1.81059707 |
| 24 | KDR | 1.76497037 |
| 25 | FES | 1.71519119 |
| 26 | MATK | 1.69823366 |
| 27 | PTK6 | 1.58325308 |
| 28 | GRK7 | 1.57758423 |
| 29 | FRK | 1.56120200 |
| 30 | IKBKB | 1.49755998 |
| 31 | MAP3K10 | 1.44541528 |
| 32 | CDC42BPA | 1.41150431 |
| 33 | ABL2 | 1.39240875 |
| 34 | DAPK2 | 1.37004325 |
| 35 | SYK | 1.34712518 |
| 36 | LATS1 | 1.33834494 |
| 37 | TXK | 1.31509054 |
| 38 | GRK6 | 1.29501556 |
| 39 | MAP3K7 | 1.25484688 |
| 40 | LYN | 1.25360880 |
| 41 | HCK | 1.24152579 |
| 42 | MAP2K3 | 1.23462489 |
| 43 | TBK1 | 1.22311739 |
| 44 | SIK3 | 1.22275562 |
| 45 | DDR2 | 1.18422011 |
| 46 | JAK2 | 1.17178965 |
| 47 | NEK9 | 1.12903590 |
| 48 | MAPK15 | 1.10988317 |
| 49 | PINK1 | 1.06845842 |
| 50 | PRKAA2 | 1.03256473 |
| 51 | MAP3K11 | 1.02314718 |
| 52 | LCK | 1.00489555 |
| 53 | MAPK4 | 0.95955502 |
| 54 | DYRK1B | 0.95428131 |
| 55 | FGFR2 | 0.92937480 |
| 56 | JAK1 | 0.91535042 |
| 57 | ERBB2 | 0.91168138 |
| 58 | IRAK3 | 0.87331604 |
| 59 | PRKD2 | 0.85574624 |
| 60 | CDK6 | 0.84917382 |
| 61 | MARK2 | 0.84465692 |
| 62 | PRKCZ | 0.84057537 |
| 63 | MARK3 | 0.83940872 |
| 64 | MAP2K6 | 0.83739435 |
| 65 | PDK4 | 0.82185421 |
| 66 | PDK3 | 0.82185421 |
| 67 | MAP3K3 | 0.80664595 |
| 68 | MAP3K14 | 0.80543120 |
| 69 | SIK2 | 0.78875875 |
| 70 | IRAK2 | 0.75496379 |
| 71 | EPHA3 | 0.75393141 |
| 72 | STK38L | 0.74277114 |
| 73 | MAPK12 | 0.71077243 |
| 74 | BMPR2 | 0.70984930 |
| 75 | TIE1 | 0.70675818 |
| 76 | ICK | 0.70529836 |
| 77 | CHUK | 0.70029217 |
| 78 | MOS | 0.69124278 |
| 79 | EPHB1 | 0.67560700 |
| 80 | PRKACG | 0.67558945 |
| 81 | CSF1R | 0.66045695 |
| 82 | TGFBR2 | 0.63565074 |
| 83 | PRKAA1 | 0.62959532 |
| 84 | CAMK2G | 0.62796790 |
| 85 | CSK | 0.61975356 |
| 86 | MET | 0.59645167 |
| 87 | STK10 | 0.59495453 |
| 88 | SMG1 | 0.59249755 |
| 89 | HIPK2 | 0.59022959 |
| 90 | MAP4K1 | 0.58078435 |
| 91 | CDK4 | 0.57852477 |
| 92 | RPS6KC1 | 0.57759217 |
| 93 | RPS6KL1 | 0.57759217 |
| 94 | RIPK1 | 0.57516911 |
| 95 | ACVR1B | 0.56996502 |
| 96 | GSK3A | 0.54923419 |
| 97 | BMX | 0.52378859 |
| 98 | IKBKE | 0.51944151 |
| 99 | CAMK1D | 0.51821835 |
| 100 | KSR2 | 0.51649964 |
| 101 | FYN | 0.51429659 |
| 102 | MAPK7 | 0.49752213 |
| 103 | RPS6KA6 | 0.47375333 |
| 104 | PIM2 | 0.46802965 |
| 105 | PRKCQ | 0.45759913 |
| 106 | TESK1 | 0.45719346 |
| 107 | PDPK1 | 0.45359683 |
| 108 | PTK2 | 0.45049223 |
| 109 | MAP3K5 | 0.42793519 |
| 110 | YES1 | 0.41712596 |
| 111 | ZAP70 | 0.41121166 |
| 112 | TESK2 | 0.40961914 |
| 113 | RPS6KA2 | 0.40949635 |
| 114 | KIT | 0.39618864 |
| 115 | TAOK2 | 0.39572370 |
| 116 | GRK1 | 0.39169559 |
| 117 | TEC | 0.39138755 |
| 118 | MTOR | 0.38745846 |
| 119 | CSNK1G1 | 0.38724665 |
| 120 | MAP3K13 | 0.38014961 |
| 121 | CAMKK2 | 0.36877618 |
| 122 | IGF1R | 0.36280754 |
| 123 | ADRBK2 | 0.35826622 |
| 124 | MAPKAPK2 | 0.35172773 |
| 125 | FGFR3 | 0.34314646 |
| 126 | LRRK2 | 0.33912130 |
| 127 | MAP2K1 | 0.32659175 |
| 128 | PDK1 | 0.31561003 |
| 129 | SGK3 | 0.31517119 |
| 130 | MAP2K2 | 0.30803879 |
| 131 | MAP3K6 | 0.30616470 |
| 132 | PRKCG | 0.30487654 |
| 133 | MAP3K1 | 0.30261819 |
| 134 | PRKCD | 0.29920612 |
| 135 | ABL1 | 0.29879306 |
| 136 | PDK2 | 0.29100491 |
| 137 | PIM1 | 0.28580767 |
| 138 | PAK4 | 0.27714196 |
| 139 | BTK | 0.27020624 |
| 140 | AKT3 | 0.24948997 |
| 141 | EGFR | 0.24795512 |
| 142 | IRAK1 | 0.23302299 |
| 143 | CAMK4 | 0.23071982 |
| 144 | PRKCA | 0.22350642 |
| 145 | ITK | 0.21186922 |
| 146 | CSNK1G3 | 0.20839439 |
| 147 | RET | 0.18910707 |
| 148 | JAK3 | 0.16597037 |
| 149 | CSNK1G2 | 0.16508432 |
| 150 | MAPK3 | 0.15872719 |
| 151 | PRKG2 | 0.15010222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54609265 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.36041810 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33771253 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16465490 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94745048 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.94647119 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88902004 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.70825522 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70764157 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.70642379 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69815676 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69786577 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67772653 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54384481 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53660618 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.49969482 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.38261841 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.37880456 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36043619 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24256516 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 2.20243742 |
| 22 | Asthma_Homo sapiens_hsa05310 | 2.18427472 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11208764 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 2.10715726 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10595976 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08561863 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 2.00215690 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.99834704 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99316503 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96385954 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.95303823 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94181941 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93893837 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92256122 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91095587 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.90353986 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89798919 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89070980 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87963446 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82614495 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.81092371 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80842792 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80668719 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74729551 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.74104031 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71695921 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70811832 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69382981 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67639697 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67514548 |
| 51 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67453627 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66654813 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.63813794 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63699680 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 1.60906219 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56332147 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54620664 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 1.54391096 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 1.53687615 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53180233 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49990086 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.49868337 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49790290 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49481691 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49292058 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46643985 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43537602 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41721723 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41467244 |
| 70 | Measles_Homo sapiens_hsa05162 | 1.41442937 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39058383 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38797484 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37181573 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36831791 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35655191 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 1.34562670 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34253835 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32788489 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31886430 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26170518 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24291492 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 1.24199187 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22110730 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17075716 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12433151 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11689425 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11139263 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09354385 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08796937 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07446534 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06644740 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03722065 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01051118 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00835199 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99775746 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97404150 |
| 97 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97095059 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96088763 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94448883 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94395648 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93859650 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.93186748 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.90423378 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89054313 |
| 105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86795448 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85430402 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.84596162 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79102030 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.78994260 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.77902373 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74424063 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74016766 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71548608 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69957224 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66614997 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66585114 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64713976 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64456968 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63299802 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63089429 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.62618959 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59505383 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56213913 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.55286392 |
| 125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53699011 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53585900 |
| 127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51196268 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49970293 |
| 129 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48753739 |
| 130 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46775804 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44224452 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43580334 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42245938 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41909875 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41897712 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40429674 |
| 137 | * Bladder cancer_Homo sapiens_hsa05219 | 0.35738561 |
| 138 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35687140 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34121756 |
| 140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33083456 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31724944 |
| 142 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31594011 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31464760 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31151443 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.31147086 |
| 146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29506746 |
| 147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24634717 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24026894 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22912370 |
| 150 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22827523 |
| 151 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22643432 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22287249 |
| 153 | Insulin resistance_Homo sapiens_hsa04931 | 0.22117361 |
| 154 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21725723 |
| 155 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20226335 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19649997 |
| 157 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12626313 |
| 158 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10090688 |
| 159 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2445218 |
| 160 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2436206 |
| 161 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2365736 |
| 162 | Mineral absorption_Homo sapiens_hsa04978 | -0.2199705 |
| 163 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2034648 |
| 164 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1946542 |
| 165 | Hepatitis C_Homo sapiens_hsa05160 | -0.1908536 |
| 166 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1715108 |
| 167 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1535141 |
| 168 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1445515 |
| 169 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1400866 |
| 170 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1278204 |
| 171 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1266226 |
| 172 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1166797 |
| 173 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1093211 |
| 174 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0976771 |
| 175 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0963904 |
| 176 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0811460 |
| 177 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0619526 |
| 178 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0318141 |
| 179 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0055639 |
| 180 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0035217 |

